• This weekend's Barron's cover story at the high cost of income inequality.
• Other featured articles look to play the growing tech divide, industrials for the recovery and biotech's next big run-up.
• Also, the prospects for COVID-19 stocks, a boat maker, REITs and more.

A cheap pill for inflammation expands the list of proven drugs to three. So says "Three Early Contenders in the Fight Against Covid-19" by Jack Hough. See how the medicines from Gilead Sciences, Inc. (NASDAQ:GILD) and others compare.

In Al Root's "This Boat Maker's Shares Could Motor Higher as Sales Revive," see why recent efforts by Brunswick Corporation (NYSE:BC) to streamline its business bode well once the crisis ends. Could the stock be worth 50% more?

See also: How The US Unemployment Surge Looks State-By-State

See why investors need to use caution when it comes to selecting real estate investment trusts, according to Lawrence C. Strauss's "REITs Are Well Off Lows. Now Is Time to Be Choosy." Is American Homes 4 Rent (NYSE:AMH) worth a look?

Also in this week's Barron's:

• How economic metrics mask the fragility of the current system
• Why Apple's WWDC event could get awkward
• How to give all Americans extra cash without raising anyone's taxes
• Unintended consequences of the Federal Reserve's bond buying
• How the coronavirus is changing travel

At the time of this writing, the author had no position in the mentioned equities.

Keep up with all the latest breaking news and trading ideas by following Benzinga on Twitter.